Susceptibility to postnatal growth retardation induced by 5-AZA-2′-deoxycytidine in utero: Gender specificity and correlation with reduced insulin-like growth factor 1

Life Sciences

Volumn 72, Issue 25, 2003, Pages 2887-2894

  Cisneros, Francisco Javier ^a   Wilson, Ralph ^b   Travlos, Gregory ^b   Anderson, Lucy M ^c   Branch, Stacy ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

5 AZA 2 deoxycytidine; Gender dimorphism; Growth retardation; In utero exposure; Reproduction

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; SOMATOMEDIN C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CORRELATION ANALYSIS; CORTICOSTERONE BLOOD LEVEL; ENERGY METABOLISM; FEMALE; GENDER; GESTATIONAL AGE; GLUCOSE BLOOD LEVEL; GROWTH RETARDATION; MALE; MOUSE; NONHUMAN; POSTNATAL GROWTH; SEXUAL BEHAVIOR; WEANING;

EID: 0344838533     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(03)00229-7     Document Type: Article

References (24)

1. Attwood J.T., Yung R.L.et al. DNA methylation and the regulation of gene transcription. Cell Mol Life Sci. 59(2):2002;241-257.
2. Baker J., Hardy M.P.et al. Effects of an Igf1 gene null mutation on mouse reproduction. Mol Endocrinol. 10(7):1996;903-918.
3. Bartke A. Role of growth hormone and prolactin in the control of reproduction: what are we learning from transgenic and knock-out animals? Steroids. 64(9):1999;598-604.
4. Branch S., Francis B.M.et al. Teratogenic effects of the demethylating agent 5-aza-2′-deoxycytidine in the Swiss Webster mouse. Toxicology. 112(1):1996;37-43.
5. Branch S., Henry-Sam G. Altered hox gene expression and cellular pathogenesis of 5-aza-2′-deoxycytidine-induced murine hindlimb dysmorphogenesis. Toxicol Pathol. 29(5):2001;501-506.
6. Butler A.A., LeRoith D. Minireview: tissue-specific versus generalized gene targeting of the igf1 and igf1r genes and their roles in insulin-like growth factor physiology. Endocrinology. 142(5):2001;1685-1688.
7. Cummings A.M. Effect of 5-azacytidine administration during very early pregnancy. Fundam Appl Toxicol. 23(3):1994;429-433.
8. Dyck M.K., Ouellet M.et al. Testes-specific transgene expression in insulin-like growth factor-I transgenic mice. Mol Reprod Dev. 54(1):1999;32-42.
9. Garcia-Aragon J., Lobie P.E.et al. Prenatal expression of the growth hormone (GH) receptor/binding protein in the rat: a role for GH in embryonic and fetal development? Development. 114(4):1992;869-876.
10. Garofalo R.S. Genetic analysis of insulin signaling in Drosophila. Trends Endocrinol Metab. 13(5):2002;156-162.
11. Le Roith D., Scavo L.et al. What is the role of circulating IGF-I? Trends Endocrinol Metab. 12(2):2001;48-52.
12. LeBlanc G.A., Waxman D.J. Feminization of rat hepatic P-450 expression by cisplatin. Evidence for perturbations in the hormonal regulation of steroid-metabolizing enzymes. J Biol Chem. 263(30):1988;15732-15739.
13. Liu J.L., Grinberg A.et al. Insulin-like growth factor-I affects perinatal lethality and postnatal development in a gene dosage-dependent manner: manipulation using the Cre/loxP system in transgenic mice. Mol Endocrinol. 12(9):1998;1452-1462.
14. Mauras N. Growth hormone, insulin-like growth factor I and sex hormones: effects on protein and calcium metabolism. Acta Paediatr Suppl. 88(433):1999;81-83.
15. Mauras N. Growth hormone and sex steroids. Interactions in puberty. Endocrinol Metab Clin North Am. 30(3):2001;529-544.
16. Mauras N., Rogol A.D.et al. Sex steroids, growth hormone, insulin-like growth factor-1: neuroendocrine and metabolic regulation in puberty. Horm Res. 45(1-2):1996;74-80.
17. McCarthy M.M. Molecular aspects of sexual differentiation of the rodent brain. Psychoneuroendocrinology. 19(5-7):1994;415-427.
18. Razin A., Cedar H. DNA methylation and gene expression. Microbiol Rev. 55(3):1991;451-458.
19. Reik W., Dean W. DNA methylation and mammalian epigenetics. Electrophoresis. 22(14):2001;2838-2843.
20. Santos F., Hendrich B.et al. Dynamic reprogramming of DNA methylation in the early mouse embryo. Dev Biol. 241(1):2002;172-182.
21. Schmahl W., Torok P.et al. Embryotoxicity of 5-azacytidine in mice. Phase- and dose-specificity studies. Arch Toxicol. 55(2):1984;143-147.
22. Vlahovic M., Bulic-Jakus F.et al. Changes in the placenta and in the rat embryo caused by the demethylating agent 5-azacytidine. Int J Dev Biol. 43(8):1999;843-846.
23. Ye P., Li L.et al. Myelination is altered in insulin-like growth factor-I null mutant mice. J Neurosci. 22(14):2002;6041-6051.
24. Zapf J. Growth promotion by insulin-like growth factor I in hypophysectomized and diabetic rats. Mol Cell Endocrinol. 140(1-2):1998;143-149.